Call for Funding to End Animal Experiments - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Call for Funding to End Animal Experiments

As the European Union (EU) debates how best to spend billions of euros worth of research funding, the Humane Society International/Europe has issued a call to develop in vitro and computational techniques that can replace the use of animals in medical experiments.

The cash will come from the EU’s Horizon 2020 initiative, which combines funding from various programs, including the seven Framework Programs, with the aim of driving growth and jobs in Europe. The initiative will run from 2014 to 2020 and will have a total funding of EUR 80 billion ($104 billion). More than a quarter of this, (EUR 24.6 billion [$32 billion]) will be dedicated to scientific research while another EUR 17.9 billion ($23.3 billion) will be used to invest in key industrial technologies, including nanotechnology and biotechnology.

According to the Humane Society International/Europe, there are many limitations in medical research that can be attributed to animal experiments. A press release claims that 92% of new drug candidates that are safe and effective in animal studies fail when given to humans.

“It is clear that in order to reverse the slow pace of progress in key areas such as cancer, asthma and degenerative neurological disorders, we need far greater investment in sophisticated tools and technologies that are more relevant to humans,” says the statement.

Troy Seidle, director of research and toxicology for Humane Society International/Europe added, “If Horizon 2020’s key objective of supporting science excellence is to be achieved, it is vital that substantial funding is focused on advanced, human-relevant research and testing methods. By investing in the development of emerging and future research technologies, we can harness the very latest human health and drug discovery advances that science has to offer and improve the quality of our medical research endeavours. Supporting industries today that are inventing the science techniques of tomorrow will also stimulate economic growth.”


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing

Click here